Stock 6660 AIM VACCINE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company AIM Vaccine Co., Ltd.

Equities

6660

CNE100005KF2

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:17 17/05/2024 BST 		5-day change 1st Jan Change
8.03 HKD 0.00% Intraday chart for AIM Vaccine Co., Ltd. -5.75% +2.29%
03-28 Aim Vaccine Submits Pre-Applications for Clinical Trials for Two Vaccines; Shares Up 3% MT
03-28 Aim Vaccine's Loss Quadruples in 2023 as Revenue Slips 6%; Shares Up 3% MT

Business Summary

AIM Vaccine Co Ltd is a China-based company principally engaged in the research and development, manufacturing and sales of vaccine. The Company's products mainly include recombinant hepatitis B vaccine, human rabies vaccine, inactivated hepatitis A vaccine, mumps vaccine, inactivated hemorrhagic fever with renal syndrome vaccine and MPSV4. The Company's products are mainly used for the treatment of hepatitis B, hepatitis A, mumps, hemorrhagic fever with renal syndrome, rabies and meningococcal diseases. The Company's vaccine candidates include messenger RNA (mRNA) corona virus disease 2019 (COVID-19) vaccine, inactivated COVID-19 vaccine, broad-spectrum COVID-19 vaccine, PCV13, PPSV23 and MCV4. The Company principally conducts its businesses in the domestic market.

Number of employees: 1,624

Sales per Business

HKD in Million2022Weight2023Weight Delta
Class II Vaccine
93.9 %
- - 1,232 93.9 % -
Class I Vaccine
6.1 %
- - 80 6.1 % -

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
1,470 100.0 % 1,312 100.0 % -10.74%

Managers

Managers TitleAgeSince
Yan Zhou CEO
 Chief Executive Officer 58 30/04/15
Wen Guan PSD
 President 57 30/11/16
Li Xin Niu DFI
 Director of Finance/CFO 52 30/09/15
Ling Liu CIO
 Chief Investment Officer 42 31/10/11
Shao Jun Jia CIO
 Chief Investment Officer 61 31/07/17
Jie Zhou BRD
 Director/Board Member 60 30/04/15
Zhen Yu Lin SAM
 Sales & Marketing 49 30/11/18
Fan Zhang PRN
 Corporate Officer/Principal 38 28/02/21
Wing Chi Lam SEC
 Corporate Secretary 34 16/06/21

Members of the board

Members of the board TitleAgeSince
Lun Ma BRD
 Director/Board Member 62 30/11/15
Xin Zhou BRD
 Director/Board Member 55 30/04/13
Yan Zhou CEO
 Chief Executive Officer 58 30/04/15
Hui Ou Yang BRD
 Director/Board Member 61 27/05/21
Wen Guan PSD
 President 57 30/11/16
Shao Jun Jia CIO
 Chief Investment Officer 61 31/07/17
Jie Zhou BRD
 Director/Board Member 60 30/04/15
Xiao Guang Guo BRD
 Director/Board Member 51 17/02/21
Jie Wen BRD
 Director/Board Member 60 27/05/21
Ting Feng Song CHM
 Chairman 55 31/01/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 718,888,888 0 0 22.09 %
Stock B 1 492,173,711 267,551,146 ( 54.36 %) 0

Shareholders

NameEquities%Valuation
Tibet Yingfeng Industrial Co. Ltd.
11.32 %
55,700,000 11.32 % 60 M $
Ningbo Economic & Tech Dev Zone State Owned Assets Mgmt Center
10.98 %
54,051,428 10.98 % 58 M $
Zhuhai Tongdao Tomorrow Investment Partnership LP
8.127 %
40,000,000 8.127 % 43 M $
Li Hua Li
8.127 %
40,000,000 8.127 % 43 M $
China Merchants Wealth Asset Management Ltd.
6.168 %
30,358,400 6.168 % 33 M $
Meihua Biotechnology Group Co. Ltd.
5.080 %
25,000,000 5.080 % 27 M $
Yan Zhou
4.994 %
24,581,165 4.994 % 27 M $
China Asset Management (Hong Kong) Ltd.
0.0508 %
249,892 0.0508 % 269 663 $
China Asset Management Co., Ltd.
0.006217 %
30,600 0.006217 % 33 021 $
Irish Life Investment Managers Ltd.
0.000391 %
1,922 0.000391 % 2 074 $
NameEquities%Valuation
Yan Zhou
57.05 %
410,135,235 57.05 % 443 M $
Tibet Yingfeng Industrial Co. Ltd.
6.162 %
44,300,000 6.162 % 48 M $
Xin Zhou
5.564 %
40,000,000 5.564 % 43 M $
Jie Zhou
5.564 %
40,000,000 5.564 % 43 M $
Meihua Biotechnology Group Co. Ltd.
3.478 %
25,000,000 3.478 % 27 M $

Company contact information

AIM Vaccine Co., Ltd.

25F, Building A 91 Jianguo Road

100020, Beijing

+

http://www.aimbio.com
address AIM Vaccine Co., Ltd.(6660)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Ratings for AIM Vaccine Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.433 CNY
Average target price
48.74 CNY
Spread / Average Target
+555.76%
Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
AIM VACCINE CO., LTD. Stock AIM Vaccine Co., Ltd.
+2.29% 1.25B
CSL LIMITED Stock CSL Limited
-2.32% 92.59B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.68% 41.43B
BIOGEN INC. Stock Biogen Inc.
-10.90% 33.49B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-19.56% 14.62B
INCYTE CORPORATION Stock Incyte Corporation
-9.06% 12.77B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.34% 11.58B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.53% 11.35B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+3.75% 8.97B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-6.32% 8.3B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 6660 Stock
  4. Company AIM Vaccine Co., Ltd.